Results 191 to 200 of about 86,450 (250)

Whole genome sequencing-based detection of extensively drug-resistant tuberculosis from Ethiopia. [PDF]

Commun Med (Lond)
Diriba G, Mollalign H, Meaza A, Getu M, Zerihun B, Alemu A, Dagne B, Abebaw Y, Weldemariam AG, Bashea C, Ali A, Seid G, Getahun M, Hailu M, Wondimu A, Getachew T, Kumsa A, Letta T, Liaulseged A, Abera NA, Abate Z, Alemu E, Challa F, Tadesse G, Abdella S, Tollera G, Dangisso MH.   +26 more
europepmc   +1 more source

Pre-extensively drug-resistant tuberculosis of the spine in a previously healthy young adult: case report. [PDF]

BMC Infect Dis
Schreurs H, Dejaegher J, Decroo T, André E, Lorent N, Henckaerts L.   +5 more
europepmc   +1 more source

Optimizing drug-resistant tuberculosis diagnosis: cost-effectiveness of rapid molecular and phenotypic assays in South Africa. [PDF]

BMC Med
Fekadu G, Tolossa T, Gao L, Tola HH, Feyissa TR, Yang L, Chen S, Chaiyakunapruk N, Asfaw E, Siegel M, Ming WK.   +10 more
europepmc   +1 more source

Spatial Analysis of Drug-Resistant Tuberculosis in Colombia (2020-2023): Departmental Rates, Clusters, and Associated Factors. [PDF]

Trop Med Infect Dis
Patiño-Palma B, Chacon-Bambague S, Bermudez-Moreno F, Peña-Briceño C, Bustos-Carvajal J, Arias-Coronel F.   +5 more
europepmc   +1 more source

Metagenomic and metatranscriptomic profiling of bronchoalveolar lavage fluid identifies microbial and host biomarkers of drug-resistant tuberculosis. [PDF]

Front Cell Infect Microbiol
Zhang H, Zhang L, Yang B, Gao C, Liu H, Zhang Y, Chen X.   +6 more
europepmc   +1 more source

From Patterns to Projections: A Spatiotemporal Distribution of Drug-Resistant Tuberculosis in Paraná, Brazil (2012-2023). [PDF]

Pathogens
Cicchelero LM, Leandro GCW, Andrade L, Meneguello JE, Caleffi-Ferracioli KR, Cardoso RF, Scodro RBL.   +6 more
europepmc   +1 more source

Predictive Analysis of Drug-Resistant Tuberculosis: Integrating Molecular Markers, Clinical Governance, and Community-Engaged Education in Rural South Africa. [PDF]

Diseases
Conham S, Sineke N, Dlatu N, Faye LM, Hosu MC, Apalata T.   +5 more
europepmc   +1 more source

Factors Predicting successful treatment outcome with novel BPaLM/BPaL regimen in individuals with drug-resistant tuberculosis: Experience From Indonesia. [PDF]

PLoS One
Soeroto AY, Purwiga A, Suryadinata H, Alisjahbana B, Makmun A, Supriatna YA, Pranggono EH, Lestari BW.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Management of drug-resistant tuberculosis

Lancet, The, 2019
Drug-resistant tuberculosis is a major public health concern in many countries. Over the past decade, the number of patients infected with Mycobacterium tuberculosis resistant to the most effective drugs against tuberculosis (ie, rifampicin and isoniazid), which is called multidrug-resistant tuberculosis, has continued to increase.
Christoph Lange, Keertan Dheda, Dumitru Chesov   +2 more
exaly   +3 more sources